(02) 9926 4726
SydneyVital.admin@sydney.edu.au

News and Event

Simultaneous PET/MR for imaging patho-physiology:the MGH experience, a seminar by Prof Georges El Fakhri.

On Tuesday, 14th November, we were honored to have Prof Georges El Fakhri  to share his knowledge and experience in the seminar – Simultaneous PET/MR for imaging patho-physiology:the MGH experience.

Read more

A report on Outcomes 2014-2018

On 5th November,  Prof Alexander Engel ( committee member and director of Sydney Vital) gave a presentation of Sydney Vital at the Surgical Grand Rounds.

After introducing our current position and roles, Prof Engel summarised our achievements and outcomes over the past four years comprehensively and addressed Vital’s plan and vision for the upcoming years.

For access to the full presentation content, please click here.

 

Read more

Sarcophagine Chelators and Cooper Isotopes for Imaging and Therapy

A presentation by Amos Hedt, from Sydney Vital’s event ‘Neuroendocrine Preceptorship’ Saturday 12th May 2018.

Read more

New Directions in NET Management

A presentation by Prof Kjell Oberg, from Sydney Vital’s event ‘Neuroendocrine Preceptorship’ Saturday 12th May 2018.

Read more

Next Generation Theranostics

A presentation by Prof Dale Bailey, from Sydney Vital’s event ‘Neuroendocrine Preceptorship’ Saturday 12th May 2018.

Read more

NETS Centre of Excellence Implications for patients

A presentation by A/Prof Nick Pavlakis, from Sydney Vital’s event ‘Neuroendocrine Preceptorship’ Saturday 12th May 2018.

Read more

Control NETS: An Update

A presentation by A/Prof Nick Pavlakis, from Sydney Vital’s event ‘Neuroendocrine Preceptorship’ Saturday 12th May 2018. 

Read more

Sydney Vital Christmas Meeting 2017

A presentation about  Sydney Vital’s  successes in translational cancer research to date and  about its new plans moving forward

Meeting held on 14th December 2017 

 

Read more

Modern Management of Thyroid Cancer: A Paradigm for Personalised Medicine

A presentation about new approaches to managing thyroid cancer, adopting a highly personalized approach tailored to a patient’s specific risk. Our speaker panel included leading national thyroid cancer experts and they will discuss how treatment pathways are balanced to optimize patient outcomes:

  • Prof Bruce Robinson: New medical therapies for high-risk thyroid cancers, offering new hope to these patients with previously poor outcomes.
  • A/Prof Diana Learoyd: The importance of not over-treating low risk thyroid cancer, discussing how expert clinicians use patient-specific features to identify those that require minimal treatment.
  • A/Prof Mark Sywak: Surgery for high risk thyroid cancer, identifying the need for careful pre-operative planning and the use of a multidiscplinary team approach.
  • Dr Geoff Schembri: Modern trends in radioactive iodine treatment, using risk-adjusted dosing.

Panel Discussion held on 8th August 2017 

 

Read more

Realising The Role of Basic Science in Translational Research Centres: Are We There Yet?

A presentation about support the goals of the following groups who are affiliated to a NSW Translational Cancer Research Centre (TCRC): Basic researchers, T2-T4 researchers
clinicians and community of practice members with an interest in the translational pipeline.

Workshop held on 17 May 2017 

 
 

Read more